SCHEMBL23998620

SCHEMBL23998620

CC(C)=C(C)N1C(=O)CCC1=O

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.31
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6553194 0.77 POLB (0.35) GLAPOLB
SCHEMBL887169 0.74 NOTUM (0.42) GLAPOLB
SCHEMBL10606912 0.69 CHRNB2 (0.34) GLA
SCHEMBL198304 0.67 CA12 (0.34) GLA
SCHEMBL23733173 0.67 CA12 (0.34) GLA
SCHEMBL1530917 0.67 KMT2A (0.40) GLAPOLB
SCHEMBL22644247 0.67 P2RX4 (0.41) POLB
SCHEMBL11823436 0.65 LMNA (0.52) POLB
SCHEMBL29121167 0.65 NOTUM (0.39) POLB
SCHEMBL1229557 0.65 POLB (0.36) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210346431-A1 SEQUENCING METHOD FOR CAR T CELL THERAPY Seattle Children's Hospital (dba Seattle Children's Research Institute) 2021-11-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210346431-A1 SEQUENCING METHOD FOR CAR T CELL THERAPY CD47, MCTS1, GZMB GLA 2474/4885POLB 210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.